Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Single nucleotide polymorphisms detection based on DNA microarray technology: HLA as a model.

Giulio Lelio Palmisano1, Laura Delfino, Monica Fiore

  • 1Department of Biology, University of Genoa, Genoa, Italy.

Autoimmunity Reviews
|October 11, 2005
PubMed
Summary

This study introduces a novel DNA microarray method for detecting single nucleotide polymorphisms (SNPs), enhancing the accuracy of human leukocyte antigen (HLA) typing and genetic variation analysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating personality pathological profiles in temporal lobe epilepsy and functional seizures according to DSM-5 alternative model for personality disorders.

Epilepsy & behavior : E&B·2026
Same author

[Hypophosphatemia in patients with iron-deficiency anemia who received intravenous iron].

Medicina·2026
Same author

Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib.

JCO precision oncology·2024
Same author

Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine.

Frontiers in oncology·2023
Same author

Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting.

Journal of clinical medicine·2022
Same author

Antioxidant Activity of Cyanidin-3-O-Glucoside and Verbascoside in an <i>in Vitro</i> Model of Diabetic Retinopathy.

Frontiers in bioscience (Landmark edition)·2022

Area of Science:

  • Genomics
  • Molecular Biology
  • Immunogenetics

Background:

  • DNA variations like SNPs are crucial for understanding genetic diversity and disease.
  • Microarray technology offers high-throughput gene analysis for rapid and accurate genotyping.
  • Human Leukocyte Antigen (HLA) typing is vital for transplantation and understanding autoimmune diseases.

Purpose of the Study:

  • To develop and validate a new DNA microarray-based methodology for detecting single nucleotide polymorphisms (SNPs).
  • To apply this method for Human Leukocyte Antigen (HLA) typing using a panel of representative HLA alleles.
  • To assess the feasibility of this technique for broader genetic and clinical investigations.

Main Methods:

  • Design of 180 oligonucleotide probes targeting polymorphic positions in HLA-A, -B, and -DRB1 loci.

Related Experiment Videos

  • Utilized a DNA microarray platform with probes featuring a central nucleotide mismatch for specific SNP detection.
  • Employed asymmetric PCR for genomic probe amplification from bone marrow cell DNA.

    • Main Results:

    • The developed DNA microarray method demonstrated reliability in identifying SNPs within the targeted HLA regions.
    • Successful application of the method for accurate HLA typing of donor samples.
    • The technique proved feasible for investigating other genetic regions and polymorphisms.

    Conclusions:

    • The novel DNA microarray approach provides a reliable and feasible technique for SNP detection and HLA typing.
    • This method facilitates the study of genetic variations relevant to autoimmune diseases and other clinical interests.
    • The technology advances the understanding of gene sequences and individual genetic profiles.